Consulta’s Allergan plc AGN Stock Holding History

Consulta’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-300,000	Closed	-$81.5M	–	15
2015 Q3	$81.5M	Buy	+300,000	New	+$92.2M	8.61%	6

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Consulta's AGN Position: Q4 2015 in Review

Consulta sold out of Allergan plc (AGN) in Q4 2015, closing a stake of 300,000 shares — an estimated $81.5M sold.

Consulta first reported a position in AGN in Q3 2015 and held it in 1 quarter. The position peaked at $81.5M in Q3 2015. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

Consulta reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
Consulta sold 300,000 Allergan plc shares in Q4 2015, an estimated $81.5M.
Consulta first reported a position in Allergan plc in Q3 2015 and held it in 1 quarter.
Consulta's Allergan plc position peaked at $81.5M in Q3 2015.
1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Consulta's 13F filing for Q4 2015, filed 16 Feb 2016.